Marker Therapeutics MRKR Cash Flow Statement (2010-2026)

NASDAQ MRKR
$1.05 -0.02 (-1.87%)
At close: Oct 1, 2026 · 4:00 PM EDT
Reported Financials

Marker Therapeutics Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

Marker Therapeutics reported cash from operations of -$3.72M and free cash flow of -$3.72M for the quarter ended Jun 2026, down 97.8% year over year. This cash flow statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-10.02M-9.76M-9.79M-9.24M-6.92M-3.86M-4.97M2.52M-2.98M-2.80M-2.39M-2.19M-2.31M-3.84M-4.80M-4.99M-2.00M-1.72M-3.94M-2.51M
Depreciation and DepletionDep. & Depletion
0.60M0.50M0.60M0.60M0.80M-1.40M0.80M
Share-based CompensationStock Comp.
1.47M1.47M1.63M0.36M0.94M0.38M0.66M-0.12M0.18M0.14M0.08M0.06M0.05M0.05M0.38M0.01M0.03M0.11M0.18M0.20M
Cash from Discontinued OperationsCash from Discont. Ops
-2.40M-2.20M-2.79M-2.99M-0.26M-0.06M
Cash from OperationsCash from Ops.
-7.54M-4.86M-12.23M-0.79M-7.65M-6.31M-5.89M-7.06M-1.13M-2.37M-3.84M-3.57M1.20M-4.70M-5.50M-1.88M-2.74M-1.90M-1.40M-3.72M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.55M0.56M0.58M0.58M0.82M0.81M0.82M
Change in Working Capital
Change in Account PayablesChange Payables
-2.95M-2.55M-2.50M0.96M-0.98M-0.06M0.61M0.81M-1.30M0.25M-0.33M-0.33M1.00M-0.20M
Change in Accured ExpensesChange Accured Exp.
2.63M1.40M-3.95M2.89M0.77M-1.03M0.11M0.09M-0.36M-0.56M0.20M-0.27M0.88M-0.80M0.34M0.18M-0.60M-0.37M0.61M-0.89M
Other Working Capital ChangesOther WC Changes
-0.10M0.50M-0.96M-0.18M-0.04M0.27M-0.13M-0.97M-0.07M0.47M-0.22M1.14M0.11M-0.78M2.03M-2.33M0.01M0.24M
Investing Activities
Capital ExpendituresCapex
Cash from Investing ActivitiesCash from Investing
-0.98M-0.35M-2.45M-2.27M-0.10M-0.13M-0.11M18.78M
Financing Activities
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
0.06M0.14M0.62M736.000.48M0.01M0.05M0.04M0.00M14.90M505.00100.009.86M
Debt Issuance and Repayment
Non-Current Debt
Current Debt
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
0.06M0.14M0.62M0.39M-0.92M0.05M-0.01M14.89M
Additional items
Change in Cash
-8.52M-5.21M-14.68M-3.00M-7.75M-6.29M-5.38M11.72M-0.65M-2.36M-3.79M-3.52M1.20M10.19M-5.50M-1.88M7.13M-1.90M-1.40M-3.72M
Free Cash FlowFCF
-7.54M-4.86M-12.23M-0.79M-7.65M-6.31M-5.89M-7.06M-1.13M-2.37M-3.84M-3.57M1.20M-4.70M-5.50M-1.88M-2.74M-1.90M-1.40M-3.72M
Net Cash FlowNCF
-8.52M-5.21M-14.68M-3.00M-7.75M-6.29M-5.38M11.72M-0.65M-2.36M-3.79M-3.52M1.20M10.19M-5.50M-1.88M7.13M-1.90M-1.40M-3.72M

Marker Therapeutics Cash Flow Statement API

Pull Marker Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MRKR&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY